HuGE Literature Finder
Records
1
-
30
| A genetic variant in the promoter of lncRNA MALAT1 is related to susceptibility of ischemic stroke. Lipids in health and disease 2020 Apr 19 (1): 57. Wang Yan, Gu Xi-Xi, Huang Hua-Tuo, Liu Chun-Hong, Wei Ye-She |
| RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer. Pathology, research and practice 2020 Feb 152898. Ta To Van, Nguyen Quang Ngoc, Chu Ha Hoang, Truong Van-Long, Vuong Linh Di |
| Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma. Bioscience reports 2019 Nov . Tang Weifeng, Chen Shuchen, Kang Mingqiang, Liu Jun, Liu Ch |
| Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations. OncoTargets and therapy 2019 12 6045-6052. Kim Ho Cheol, Kang Yeh Rim, Ji Wonjun, Kim Yeon Joo, Yoon Shinkyo, Lee Jae Cheol, Choi Chang-M |
| High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer. Asian Pacific journal of cancer prevention : APJCP 2019 08 20 (8): 2319-2326. Korphaisarn Krittiya, Pongpaibul Ananya, Roothumnong Ekkapong, Pongsuktavorn Khontawan, Thamlikitkul Lucksamon, Anekpuritanang Tauangtham, Poungvarin Naravat, Thongnoppakhun Wanna, Pithukpakorn Man |
| PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1. Thoracic cancer 2019 01 10 (1): 103-110. Lee Jongmin, Park Chan Kwon, Yoon Hyoung-Kyu, Sa Young Jo, Woo In Sook, Kim Hyo Rim, Kim Sue Youn, Kim Tae-Ju |
| Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR-mutated non-small cell lung cancer. Thoracic cancer 2018 Jul . Lee Yunkyoung, Park Sojung, Kim Woo Sung, Lee Jae Cheol, Jang Se Jin, Choi Jene, Choi Chang-M |
| A study of therapy targeted EGFR/ALK mutations in Indian patients with lung adenocarcinoma: A clinical and epidemiological study. Medical journal, Armed Forces India 2018 Apr 74 (2): 148-153. Rana Vandana, Ranjan Praveer, Jagani Rajat, Rathi K R, Kumar Dharmesh, Khera Anur |
| Assessment of EGFR mutation status in Tunisian patients with pulmonary adenocarcinoma. Current research in translational medicine 2018 Mar . Arfaoui Toumi A, Blel A, Aloui R, Zaibi H, Ksentinini M, Boudaya M S, Znaidi N, Zidi Y, Aouina H, Rammeh Rommani |
| KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma. Histopathology 2018 Feb . Mehrad Mitra, Roy Somak, LaFramboise William A, Petrosko Patti, Miller Caitlyn, Incharoen Pimpin, Dacic San |
| Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma. Clinical chemistry 2018 Jan . Kim Min Kyeong, Woo Sang Myung, Park Boram, Yoon Kyong-Ah, Kim Yun-Hee, Joo Jungnam, Lee Woo Jin, Han Sung-Sik, Park Sang-Jae, Kong Sun-You |
| Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain. BMC cancer 2018 01 18 (1): 106. Arriola Edurne, García Gómez Ramón, Diz Pilar, Majem Margarita, Martínez Aguillo Maite, Valdivia Javier, Paredes Alfredo, Sánchez-Torres José Miguel, Peralta Muñoz Sergio, Barneto Isidoro, Gutierrez Vanesa, Andrade Santiago Jesús Manuel, Aparisi Francisco, Isla Dolores, Ponce Santiago, Vicente Baz David, Artal Angel, Amador Mariluz, Provencio Maria |
| IL18 rs360719 A>G, IL18R1 rs13015714 G>T, IL18RAP rs917997 C>T and IL28B rs8099917 T>G polymorphisms and risk of gastric cardiac adenocarcinoma. Molecular and clinical oncology 2017 Dec 7 (6): 1101-1106. Yin Jun, Dong Changqing, Tang Weifeng, Liu Ruiping, Chen Suocheng, Zheng Liang, Gu Haiyo |
| [EGFR and KRAS Gene Mutations in 754 Patients with Resectable Stage I-IIIa Non-small Cell Lung Cancer and Its Clinical Significance]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2017 Sep 20 (9): 617-622. Zhao Jing, Gao Jie, Guo Liping, Hu Xiaoxu, Liu Qi, Zhao Jinyin, Liu Licheng, Jiang Jun, Wang Mengzhao, Liang Zhiyong, Xu Yan, Chen Minjiang, Zhang Li, Li Longyun, Zhong W |
| [Clinicopathologic characteristics of epidermal growth factor receptor mutations in non-small cell lung cancer in Xinjiang region]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2017 May 46 (5): 309-313. Shi Y, Pan Z, Cui W L, Ma Z P, Pang X L, Zhang W, Ma Y |
| Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components. Pathology, research and practice 2017 May . Galuppini Francesca, Salmaso Roberta, Valentini Elisa, Lanza Cristiano, Maretto Isacco, Nitti Donato, Rugge Massimo, Fassan Matt |
| A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens. Oncology reports 2017 Feb 37 (2): 1020-1026. Asaka Shiho, Yoshizawa Akihiko, Matsuda Kazuyuki, Yamaguchi Akemi, Yamamoto Hiroshi, Shiina Takayuki, Nakata Rie, Ogawa Kaoru, Zhang Meng, Honda Takayu |
| EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6. British journal of cancer 2016 Dec . Wu Yi-Long, Sequist Lecia V, Hu Cheng-Ping, Feng Jifeng, Lu Shun, Huang Yunchao, Li Wei, Hou Mei, Schuler Martin, Mok Tony, Yamamoto Nobuyuki, O'Byrne Kenneth, Hirsh Vera, Gibson Neil, Massey Dan, Kim Miyoung, Yang James Chih-Hs |
| Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies. The Journal of molecular diagnostics : JMD 2016 Jan . Fisher Kevin E, Zhang Linsheng, Wang Jason, Smith Geoffrey H, Newman Scott, Schneider Thomas M, Pillai Rathi N, Kudchadkar Ragini R, Owonikoko Taofeek K, Ramalingam Suresh S, Lawson David H, Delman Keith A, El-Rayes Bassel F, Wilson Malania M, Sullivan H Clifford, Morrison Annie S, Balci Serdar, Adsay N Volkan, Gal Anthony A, Sica Gabriel L, Saxe Debra F, Mann Karen P, Hill Charles E, Khuri Fadlo R, Rossi Michael |
| Association of HLA-G*01:01:02:01/G*01:04:01 polymorphism with gastric adenocarcinoma. Human immunology 2015 Nov . Khorrami Samaneh, Rahimi Roghayeh, Mohammadpour Hemn, Bahrami Salahadin, Yari Fatemeh, Poustchi Hossein, Malekzadeh Re |
| Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility. Oncotarget 2015 Aug 6 (25): 20863-74. Alvi Muhammad A, McArt Darragh G, Kelly Paul, Fuchs Marc-Aurel, Alderdice Matthew, McCabe Clare M, Bingham Victoria, McGready Claire, Tripathi Shailesh, Emmert-Streib Frank, Loughrey Maurice B, McQuaid Stephen, Maxwell Perry, Hamilton Peter W, Turkington Richard, James Jacqueline A, Wilson Richard H, Salto-Tellez Manu |
| Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer. Clinical and experimental medicine 2015 Apr . Nico? Marcin, Krawczyk Pawe?, Jarosz Bo?ena, Sawicki Marek, Szumi??o Justyna, Trojanowski Tomasz, Milanowski Janu |
| Variant TP53BP1 rs560191 G>C is associated with risk of gastric cardia adenocarcinoma in a Chinese Han population. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2015 Apr 27 (2): 156-62. Zhang Sheng, Tang Weifeng, Ding Guowen, Liu Chao, Liu Ruiping, Chen Suocheng, Gu Haiyong, Yu Chunzh |
| [Relationship between histopathologic characteristics and epidermal growth factor receptor mutation in lung adenocarcinoma]. Zhonghua bing li xue za zhi Chinese journal of pathology 2015 Mar 44 (3): 170-174. Wang Kai, Gong Huilin, Li Xiaofeng, Yang Zhe, Cao Peilong, Wang Chunbao, Jiang Yina, Wang Hongyan, Wang Yili, Zhang Guanj |
| Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung. OncoTargets and therapy 2015 8 117-23. Doval Dc, Prabhash K, Patil S, Chaturvedi H, Goswami C, Vaid Ak, Desai S, Dutt S, Veldore Vh, Jambhekar N, Mehta A, Hazarika D, Azam S, Gawande S, Gupta |
| Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study. Translational respiratory medicine 2014 Dec 2 (1): 9. Hantson Inge, Dooms Christophe, Verbeken Eric, Vandenberghe Peter, Vliegen Liesbet, Roskams Tania, Borght Sara Vander, Nackaerts Kris, Wauters Isabelle, Vansteenkiste Joh |
| Associations between epidermal growth factor receptor gene mutation and serum tumor markers in advanced lung adenocarcinomas: a retrospective study. Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 2014 Sep 29 (3): 156-61. Pan Ying-qiu, Shi Wei-wu, Xu Dan-ping, Xu Hui-hui, Zhou Mei-ying, Yan Wei-h |
| Clinical characteristics, tumor, node, metastasis status, and mutation rate in domain of epidermal growth factor receptor gene in serbian patients with lung adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2014 Sep 9 (9): 1406-10. Zaric Bojan, Stojsic Vladimir, Kovacevic Tomi, Sarcev Tatjana, Tepavac Aleksandar, Jankovic Radmila, Spasic Jelena, Radosavljevic Davorin, Zarogoulidis Paul, Vukobradovic-Djoric Nevena, Perin Branisl |
| Interleukin 17A rs3819024 A>G polymorphism is associated with an increased risk of gastric cardia adenocarcinoma in a Chinese population. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2014 Aug 19 (5): 411-6. Ren Zhengbing, Li Mingna, Liu Ruiping, Wang Yong, Gu Haiyo |
| Epidermal growth factor receptor and anaplastic lymphoma kinase mutation in adenocarcinoma lung: Their incidence and correlation with histologic patterns. Indian journal of pathology & microbiology 0 62 (1): 24-30. Gupta Pankaj, Gowrishankar Swarnalata, Swain Meenaks |
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 28, 2021
- Content source: